Factors associated to aspirin failure for secondary stroke prevention;Factores asociados al fracaso de la aspirina en la prevencion secundaria del accidente cerebrovascular isquemico

Medicina Clinica

Volumn 109, Issue 15, 1997, Pages 569-572

  Chamorro, A ^a   Blanc, R ^b   Ascaso, C ^a   Saiz, A ^a   Vila, N ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL;

AGING; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE;

AGED; ASPIRIN; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 0030734899     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
2. Dyken ML, Barnett HJM, Easton JD, Fields WS, Fuster V, Hachinski V et al. Low-dose aspirin and stroke. «It ain't necessary so». Stroke 1992; 23: 1.395-1.399.
3. Van Gijn J, Warlow CP, Norrving B. Low-dose aspirin [carta]. Stroke 1993; 24: 476.
4. Helgason CM, Bolin KM, Hoff JA, Winkler SR, Mangat A, Tortorice KL et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke 1994; 25: 2.331-2.336.
5. Patrono C. Aspirin an antiplatelet drug. N Engl J Med 1994; 330: 1.287-1.294.
6. Chimowitz MI, Furlan AJ, Nayak S, Sila CA. Mechanism of stroke in patients taking aspirin. Neurology 1990; 40: 1.682-1.685.
7. Bornstein NM, Karepov VG, Aronovich BD, Gorbulev AY, Treves TA, Korcyn AD. Failure of aspirin treatment after stroke. Stroke 1994; 25: 275-277.
8. Mon TA, VanDongen R, Douglas AJ, McCulloch RK, Burke V. Differential effect of aspirin on platelet aggregation in IDDM. Diabetes 1992; 41: 261-266.
9. Grotta JC, Lemak NA, Gary H, Fields WS, Vital D. Does platelet antiaggregant therapy lessens the severity of stroke? Neurology 1985; 35: 632-636.
10. Damasio H. A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983; 40: 138-142.
11. Polis AT, Foulkes MA, Mohr JP, Hier DB, Price TR, Wolf PA. Representing computerized tomographic scans using the GAMP procedure in SAS/Graph. Proc SAS users group Int Conference 1989; 14: 1.162-1.165.
12. Chamorro A, Vila N, Saiz A, Alday M, Tolosa E. Early anticoagulation after large cerebral infarction: a safety study. Neurology 1995; 45: 861-865.
13. Foulkes M, Wolf PA, Price TR, Mohr JP, Hier DB. The stroke data bank: design, methods, and baseline characteristics. Stroke 1988; 19: 547-554.
14. Chamorro A, Saiz A, Vila N, Ascaso C, Blanc R, Alday M et al. Contribution of arterial pressure to the clinical expression of lacunar infarction. Stroke 1996; 27: 388-392.
15. Nilsson J, Svenson J, Hamsten A, De Faire U. Increased platelet-derived mitogenic activity in plasma of young patients with coronary atherosclerosis. Atherosclerosis 1986; 61: 237.
16. Kristensen SD, Roberts KM, Kishk YT, Martin JF. Accelerated atherogenesis occurs following platelet destruction and increases in megakaryocyte size and DNA content. Eur J Clin Invest 1990; 20: 239.
17. Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995; 332: 238-248.
18. Antonov AS, Key NS, Smirnov MD, Jacob HS, Vercellotti GM, Smirnov VN. Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992; 141: 673-683.
19. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993; 342: 1.255-1.262.
20. Laupacis A, Albers G, Dalen G, Dunn M, Feingerg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest 1995; 108 (Supl): 252-359.
21. Joseph R, Han E, Grundfeled S, Welch KMA. Prior use of aspirin may reduce stroke severity [resumen]. Ann Neurol 1989; 26: 131.
22. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpirazone in threatened stroke. N Engl J Med 1987; 299: 53-59.
23. Koudstaal PJ, Ciabattoni G, Van Gijn J, Nieuwenhuis HK, De Groot PG, Sixma JJ et al. Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke 1993; 24: 219-223.
24. Weitz JI, Califf RM, Ginsberg JS, Hirsh J, Théroux P. New antithrombotics. Chest 1995; 108 (Supl): 471-485.
25. Hijdra A, Verbeeten B Jr, Verhulst JAPM. Relation of leukoaraiosis to lesion type in stroke patients. Stroke 1990; 21: 890-894.
26. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318: 1.728-1.734.